ALDX
Price
$3.93
Change
-$0.01 (-0.25%)
Updated
Apr 26, 6:59 PM EST
5 days until earnings call
ORMP
Price
$2.46
Change
+$0.16 (+6.96%)
Updated
Apr 26, 6:59 PM EST
32 days until earnings call
Ad is loading...

Compare predictions ALDX vs ORMP

Header iconALDX vs ORMP Comparison
Open Charts ALDX vs ORMPBanner chart's image
Aldeyra Therapeutics
Price$3.93
Change-$0.01 (-0.25%)
Volume$144.62K
CapitalizationN/A
Oramed Pharmaceuticals
Price$2.46
Change+$0.16 (+6.96%)
Volume$58.45K
CapitalizationN/A
View a ticker or compare two or three
ALDX vs ORMP Comparison Chart

Loading...

ALDXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
ORMPDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ALDX vs. ORMP commentary
Apr 27, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALDX is a Hold and ORMP is a StrongBuy.

COMPARISON
Comparison
Apr 27, 2024
Stock price -- (ALDX: $3.93 vs. ORMP: $2.46)
Brand notoriety: ALDX and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALDX: 42% vs. ORMP: 58%
Market capitalization -- ALDX: $233.5M vs. ORMP: $99.68M
ALDX [@Biotechnology] is valued at $233.5M. ORMP’s [@Biotechnology] market capitalization is $99.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $556.22B to $0. The average market capitalization across the [@Biotechnology] industry is $2.54B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALDX’s FA Score shows that 1 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • ALDX’s FA Score: 1 green, 4 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, ALDX is a better buy in the long-term than ORMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALDX’s TA Score shows that 5 TA indicator(s) are bullish while ORMP’s TA Score has 5 bullish TA indicator(s).

  • ALDX’s TA Score: 5 bullish, 5 bearish.
  • ORMP’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ALDX and ORMP are a good buy in the short-term.

Price Growth

ALDX (@Biotechnology) experienced а +1.81% price change this week, while ORMP (@Biotechnology) price change was +8.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.69%. For the same industry, the average monthly price growth was -8.16%, and the average quarterly price growth was +1262.42%.

Reported Earning Dates

ALDX is expected to report earnings on Aug 02, 2024.

ORMP is expected to report earnings on Aug 07, 2024.

Industries' Descriptions

@Biotechnology (+1.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ALDX with price predictions.
OPEN
A.I.dvisor published
a Summary for ORMP with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ALDX($233M) has a higher market cap than ORMP($99.7M). ALDX YTD gains are higher at: 11.966 vs. ORMP (6.494).
ALDXORMPALDX / ORMP
Capitalization233M99.7M234%
EBITDAN/AN/A-
Gain YTD11.9666.494184%
P/E RatioN/A17.57-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
ALDX vs ORMP: Fundamental Ratings
ALDX
ORMP
OUTLOOK RATING
1..100
2359
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
63
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9585
PRICE GROWTH RATING
1..100
3652
P/E GROWTH RATING
1..100
10072
SEASONALITY SCORE
1..100
3150

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALDX's Valuation (29) in the Biotechnology industry is somewhat better than the same rating for ORMP (63) in the Pharmaceuticals Other industry. This means that ALDX’s stock grew somewhat faster than ORMP’s over the last 12 months.

ALDX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ORMP (100) in the Pharmaceuticals Other industry. This means that ALDX’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's SMR Rating (85) in the Pharmaceuticals Other industry is in the same range as ALDX (95) in the Biotechnology industry. This means that ORMP’s stock grew similarly to ALDX’s over the last 12 months.

ALDX's Price Growth Rating (36) in the Biotechnology industry is in the same range as ORMP (52) in the Pharmaceuticals Other industry. This means that ALDX’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's P/E Growth Rating (72) in the Pharmaceuticals Other industry is in the same range as ALDX (100) in the Biotechnology industry. This means that ORMP’s stock grew similarly to ALDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALDXORMP
RSI
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
66%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
71%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
65%
Bullish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 10 days ago
83%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 12 days ago
82%
Bearish Trend 10 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
79%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Ad is loading...
ALDXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
ORMPDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ASERX98.571.88
+1.94%
American Century Select R
PRIGX17.180.09
+0.53%
T. Rowe Price Glbl Val Eq Cl I
PPQSX10.590.05
+0.47%
Principal MidCap Growth III R4
DNLCX50.160.14
+0.28%
BNY Mellon Active MidCap C
UTPIX57.12-0.99
-1.70%
ProFunds Utilities UltraSector Inv

ALDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALDX has been loosely correlated with OMER. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ALDX jumps, then OMER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALDX
1D Price
Change %
ALDX100%
-0.25%
OMER - ALDX
48%
Loosely correlated
+2.94%
CANF - ALDX
46%
Loosely correlated
+3.13%
ORMP - ALDX
45%
Loosely correlated
+6.96%
CDMO - ALDX
35%
Loosely correlated
+0.41%
ARRY - ALDX
35%
Loosely correlated
+3.85%
More

ORMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with KRYS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
+6.96%
KRYS - ORMP
48%
Loosely correlated
+0.77%
VXRT - ORMP
48%
Loosely correlated
+7.79%
MORF - ORMP
46%
Loosely correlated
+0.32%
ARCT - ORMP
45%
Loosely correlated
+1.45%
CRBU - ORMP
45%
Loosely correlated
-1.33%
More